Nissim Darvish
Chairman
Prof. Ayelet Erez
PI - Cachexia expert
Ronen Sarusi
CEO, Co-founder
Omer Goldman Senior researcher
Dror Melamed
President, CTO
Prof. Avi Schruder PI- Drug delivery
I wholeheartedly endorse the development of this drug as a critical step towards addressing an unmet medical need in oncology
Prof. Ido Wolf Head, Oncology Division
Tel Aviv Sourasky Medical Center
…this drug has a promising potential… expected to extend the survival of such patients and may be disruptive to the current desperate situation…
Prof. Talia Golan
Medical Director Phase I Clinical Trial Unit & Pancreatic Cancer Program
Sheba Medical Center